Wachtell-Led Pfizer Closes Metsera Deal Worth Up To $10B
By Al Barbarino · November 13, 2025, 4:52 PM EST
Pfizer Inc. said Thursday that it has successfully completed its acquisition of Metsera Inc., securing the obesity drug developer after a tumultuous bidding war with Novo Nordisk and court fights that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login